Clik here to view.
Life Sciences Hiring Index Posts Slight Decline to End Record Year
WEST ORANGE, N.J. ZRG Partners, Inc. has announced the final findings for 2014 with their fourth quarter Global Life Sciences Hiring Index. Despite a small drop from Q3, 2014 ended with the highest...
View ArticleClik here to view.
Deficient Cold Chain Facilities Will Present New Prospects for Vendors in the...
LONDON The Aseptic Packaging Market in APAC Region is expected to grow at a CAGR of 11.35 percent from 2014-2019, according to a new report from research firm TechNavio. About the Report According...
View ArticleClik here to view.
Acucela Received a Request to Hold a Special Meeting of Shareholders
SEATTLE Acucela Inc. (TOKYO: 4589), a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening...
View ArticleClik here to view.
ENMORE: Immunotherapy Industry Summit 2015 — Cellular Immunotherapy Focus
SHANGHAI With the development of clinical translation, the immunotherapy industry, especially the cellular immunotherapy, is gaining popularity as an emerging biotherapy method. On April 10-11,...
View ArticleClik here to view.
Edwards Highlights Integrated Abatement Solutions at SEMICON® Korea 2015
CRAWLEY, England Edwards Limited will showcase its integrated vacuum and abatement solutions at SEMICON® Korea, taking place 4-6 February 2015, in Seoul. “Edwards continually strives to lower...
View ArticleClik here to view.
Aurinia Pharmaceuticals Announces Recently Granted Nanomicellar Formulation...
VICTORIA, British Columbia Aurinia Pharmaceuticals Inc. (the “Company”) (NASDAQ:AUPH / TSX:AUP) today announced that the Company has recently been granted patents by the Japanese and Chinese patent...
View ArticleClik here to view.
THERAVECTYS Obtains Orphan Drug Designation from the European Medicines...
PARIS “On World Cancer Day 2015, we are proud to be one of the most innovative players in the immuno-oncology space, developing a new kind of treatment for more sustainable remission. In our...
View ArticleClik here to view.
Executive Steering Committee Announced for ChinaBio® Partnering Forum 2015...
CARLSBAD, Calif. & SHANGHAI The organizers of ChinaBio® Partnering Forum 2015 have just announced that the conference will be held April 15–16 in Shanghai. The event is China’s premier life...
View ArticleClik here to view.
Sorin Group Receives Regulatory Approval for New Generation MRI Compatible...
TOKYO Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today that it has received approval from Japan’s...
View ArticleClik here to view.
テラヴェクティスがBpifranceより190万ユーロの資金を調達
パリ （ビジネスワイヤ） — 世界の主要な感染性疾患とがんに対する新世代の治療用ワクチンと免疫療法の開発を専門とするフランスのバイオテクノロジー企業テラヴェクティスは、Bpifranceより、イノベーション発展支援プログラム（ADI）の一環として、返済可能な前払い金の形で、190万ユーロの助成金を交付されたと発表しました。...
View ArticleClik here to view.
Clik here to view.
NanoSpeed Announces Distribution Partnership with Unilab for Test4D™
EDMONTON, Alberta NanoSpeed is pleased to announce that they have appointed an exclusive distributor in the Philippines for their 25-OH Vitamin D deficiency test kit – Test4D™. Unilab Laboratories,...
View ArticleClik here to view.
Patent Expiries Will Pave the Way for the Generic Drugs Market in Japan:...
LONDON The Generic Drugs Market in Japan is expected to grow at a CAGR of 8.16 percent from 2014-2019, says research firm TechNavio. About the Report According to the latest report by TechNavio, the...
View ArticleClik here to view.
Takeda Announces That the First Interim Analysis of the Phase 3 Study of Oral...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced that the randomized, double-blind, placebo-controlled TOURMALINE-MM1 pivotal Phase 3 trial...
View ArticleClik here to view.
Rosetta Genomics Receives First Patent Allowance in Japan
PRINCETON, N.J. & REHOVOT, Israel Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company received a Notice of...
View ArticleClik here to view.
Labcyte Commends Institute for Molecular Medicine Finland – Pfizer Leukemia...
SUNNYVALE, Calif. Labcyte, a company revolutionizing life science research with its patented acoustic liquid handling technology, today praised the results of an international collaboration between...
View ArticleClik here to view.
MerLion announces FDA approval of finafloxacin otic suspension
SINGAPORE MerLion Pharmaceuticals (MerLion), a biopharmaceutical company headquartered in Singapore with clinical development operations in Berlin, Germany, today announced that an otic suspension...
View ArticleClik here to view.
The Philippines is the 19th Country to Clear CEL-SCI for Patient Enrollment...
VIENNA, Va. CEL-SCI Corporation (NYSE MKT: CVM) today announced that the Philippines Regulatory Agency (PFDA) has cleared the Company to commence patient enrollment of the Phase III head and neck...
View ArticleClik here to view.
Neurovive Pharmaceutical: New Subsidiary Secures Funding of Just over USD 3 m...
STOCKHOLM Regulatory News: NeuroVive (STO:NVP) has established a subsidiary in Taiwan, NeuroVive Pharmaceutical Asia, Inc., which has secured initial funding totaling USD 3,255 m. The funding is...
View ArticleClik here to view.
Deep Knowledge Ventures and Insilico Medicine Enter into a Convertible Bridge...
HONG KONG Today Deep Knowledge Ventures, a Hong Kong-based venture fund specializing in early and growth stage investments in Big Data and Life Sciences industries, announced the completion and...
View Article